Strongyloides hyperinfection: a preventable complication of immunosuppression

• 1 Royal Melbourne Hospital, Melbourne, VIC
• 2 Peter MacCallum Cancer Centre, Melbourne, VIC
• 3 Melbourne Health, Melbourne, VIC
• 4 Peter Doherty Institute for Infection and Immunity, Melbourne, VIC
• 5 Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC

---

• 1. Miller A, Smith ML, Judd JA, Speare R. Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities. PLoS Negl Trop Dis 2014; 8: e3141.
• 2. Greaves D, Coggle S, Pollard C, et al. Strongyloides stercoralis infection. BMJ 2013; 347: f4610.
• 3. Buonfrate D, Requena‐Mendez A, Angheben A, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 2013; 13: 78.
• 4. eTG Complete. Strongyloides stercoralis prophylaxis in immunocompromised adults without HIV infection. West Melbourne (Australia): Therapeutic Guidelines Limited; 2019. https://www.tg.org.au/ (viewed June 2021).
• 5. Polanco L, Gutiérrez L, Cardona Arias J. [Diagnosis of Strongyloides stercoralis infection. Meta‐analysis on evaluation of conventional parasitological methods (1980–2013)] [Spanish]. Rev Esp Salud Publica 2014; 88: 581‐600.
• 6. Baudou E, Lespine A, Durrieu G, et al. Serious ivermectin toxicity and human ABCB1 nonsense mutations. N Engl J Med 2020; 383: 787‐789.
• 7. Muhi S, Ko DK, McGuinness SL, et al. A mixed‐method analysis of screening for Strongyloides stercoralis prior to immunosuppression: a problem of limited bandwidth? Intern Med J 2020; doi: [Epub ahead of print].